China approves sales of first domestically developed 13-valent pneumonia vaccine

China approves sales of first domestically developed 13-valent pneumonia vaccine
Reuters: Health
China has approved a pneumonia vaccine developed by domestic drugmaker Walvax Biotechnology, its National Medical Products Administration said in a notice on Tuesday, offering an alternative to Pfizer's market-dominating Prevnar 13.


Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Women in India Report Higher Sleep Deprivation Than Men

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018